The Effect of Near-infrared Light Therapy on Brain Function and Cognition in Young and Older Adults
University of Oklahoma · NCT07209683
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21–85 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 30
- US sites recruiting
- 1
- Study start
- October 1, 2025
- Record last updated
- February 6, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this pilot clinical trial is to test whether transcranial photobiomodulation (tPBM), a non-invasive brain stimulation technique using near-infrared light, can improve brain blood flow regulation (neurovascular coupling) and cognitive function in older adults.
The main questions it aims to answer are
- Does tPBM enhance neurovascular coupling responses during memory and finger tapping tasks?
- Are these improvements linked to better cognitive performance and lower levels of brain inflammation and oxidative stress?
Researchers will compare an active tPBM treatment arm to a sham treatment arm to see if tPBM leads to measurable improvements in brain activity and cognitive function compared to no active stimulation.
Participants will
- Receive either active tPBM or sham stimulation sessions for 4 weeks, every other day using a portable intervention device.
- Complete questionnaires and an iPAD-based cognitive testing protocol
- Complete memory and motor tasks while their brain activity is measured using non-invasive techniques: simultaneous functional near-infrared spectroscopy (fNIRS) and electroencephalography (EEG), transcranial doppler (TCD) flowmetry.
- Retinal vessel reactivity will be measured during flickering light stimulus using a special camera (dynamic vessel analysis, DVA).
- Provide blood samples to test for biomarkers of inflammation, oxidative stress and brain cell damage.
Being studied: transcranial photobiomodulation
Conditions: Cognition; Neurovascular Coupling Mechanism and Cognitive Function; Neurovascular Control; Brain Aging; Brain Activity
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age: 21-85 years of age
- Adequate hearing and visual acuity to participate in the examinations
- Ability to read and write in English
- Competence to provide informed consent
Exclusion Criteria
- Active CNS disease including multiple sclerosis, uncontrolled seizures, active brain cancer
- Cerebrovascular accident other than TIA within 60 days prior to Visit 0
- Major psychiatric disease, including major depression not currently controlled on medications, alcohol or drug abuse
- Participant currently uses commercial brain stimulation / neuromodulation device or an experimental device as part of a research study, e.g. tDCS, tACS, TBS, DBS, TMS, TPBM, etc.
- Participant currently takes dietary supplements with an expected cerebrovascular benefit, such as NAD- or NR-supplement, L-citrulline, urolithin
- Unstable medical condition, including uncontrolled diabetes, chronic heart issues, heart failure, chronic obstructive pulmonary disease, Stage 2 hypertension uncontrolled by medication (>160/100 mmHg)
- Any other medical condition or medication which, in the opinion of investigator, would render the patient inappropriate or too unstable to complete the study protocol.
- Pregnancy or trying to become pregnant in the next 1 months (self-reported), breastfeeding
Recruiting US locations
University of Oklahoma Health Campus
Oklahoma City, OK 73104
Site contact: Peter Mukli Mukli, MD PhD · 405-271-8001 · peter-mukli@ou.edu
Study contacts (from the official record)
- Peter Mukli, MD, PhD · +1 (405) 271-8001 · peter-mukli@ou.edu
- Norbert S Dosa, MD · +1 (405) 271-8130 · norbert-dosa@ou.edu
Similar studies in Oklahoma
All healthy volunteers studies in Oklahoma →- RecruitingHealthy volunteersPhase 1
A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).
Merck Sharp & Dohme LLC
- Location
- Oklahoma City, OK + 5 other US sites
- Eligibility basics
- Ages 12–30
- RecruitingHealthy volunteersPhase 1/Phase 2
Neural Response to Inflammatory Challenge in Major Depressive Disorder
Laureate Institute for Brain Research, Inc.
- Location
- Tulsa, OK
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Moore, OK + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingHealthy volunteers
Galleri® in the Medicare Population.
GRAIL, Inc.
- Location
- Oklahoma City, OK + 70 other US sites
- Eligibility basics
- Ages 50+